Last update May 10, 2021
Very Low Risk
It is an antihistamine with a benzimidazole structure.
Indicated in the treatment of allergic rhinitis and conjunctivitis.
Ophthalmic administration in eye drops or oral in two daily doses.
It is excreted in human milk in clinically insignificant amounts and no short-term or long-term problems have been observed in an infant whose mother took 2 mg once daily (Saito 2020).
The small dose and poor plasma absorption of most topical ophthalmological preparations make it unlikely that significant amounts will transfer into breastmilk.
The small dose and poor plasma absorption of most topical ophthalmological preparations make it unlikely that significant amounts will transfer into breast milk.
Ophthalmic use of emedastine usually does not produce measurable plasma concentrations: following ophthalmic administration of emedastine, plasma drug concentrations were between 0.3 and 0.5 ng / ml or were below the limit of quantification, 0.3 ng / ml (EMA 2009).
We do not have alternatives for Emedastine Fumarate since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2012 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM